The Efficacy and Safety of Additional Anti-HER2-Targeting Drugs in the Treatment of HER2-Positive Advanced Breast Cancer: A Meta-Analysis

Du, NN; Chen, BS; Shen, ZF; Zhou, B; Fu, XJ; Mao, DY; Mao, FY; Ng, DM; Khadaroo, PA; Yang, L

Yang, L (corresponding author), Ningbo Yinzhou 2 Hosp, Emergency Med Ctr, 998 North Qianhe Rd, Ningbo 315100, Zhejiang, Peoples R China.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021; 21 (14): 1931

Abstract

Background: HER2-positive breast cancer patients account for one-fifth of the total breast cancer population. Besides, more anti-HER2-targeting drugs ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索